{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:44:28Z","timestamp":1747205068663,"version":"3.40.5"},"posted":{"date-parts":[[2024,5,3]]},"group-title":"In Review","reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,1,15]]},"abstract":"<title>Abstract<\/title>\n        <p>Current gene therapy for Duchenne muscular dystrophy (DMD) utilizes adeno-associated virus (AAV) to deliver miniaturized dystrophin (micro-dystrophin or \u00b5Dys), which does not provide full protection for striated muscles as it lacks many important functional domains within full-length (FL) dystrophin. Here we develop a triple vector system to deliver FL-dystrophin into skeletal and cardiac muscles. We rationally split FL-dystrophin into three fragments (N, M, and C) linked to two orthogonal pairs of split intein, allowing efficient, unidirectional assembly of FL-dystrophin. The three fragments packaged in myotropic AAV (MyoAAV4A) restore FL-dystrophin expression in both skeletal and cardiac muscles in male <italic>mdx<\/italic><sup><italic>4cv<\/italic><\/sup> mice. Dystrophin-glycoprotein complex components are also restored in the sarcolemma of dystrophic muscles. MyoAAV4A-delivered FL-dystrophin significantly improves muscle histopathology, contractility, and overall strength comparable to \u00b5Dys, but unlike \u00b5Dys, it also restores defective ERK signaling in heart. The FL-dystrophin gene therapy therefore promises to offer superior protection for DMD.<\/p>","DOI":"10.21203\/rs.3.rs-3867299\/v1","type":"posted-content","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T16:37:55Z","timestamp":1714754275000},"source":"Crossref","is-referenced-by-count":0,"title":["Systemic Delivery of Full-Length Dystrophin in DMD Mice"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-9186","authenticated-orcid":false,"given":"Renzhi","family":"Han","sequence":"first","affiliation":[{"name":"Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-7460","authenticated-orcid":false,"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4295-1536","authenticated-orcid":false,"given":"Weidong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Indiana University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-998X","authenticated-orcid":false,"given":"Roland","family":"Herzog","sequence":"additional","affiliation":[{"name":"Indiana University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","article-title":"Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis","volume":"35","author":"Landfeldt E","year":"2020","unstructured":"Landfeldt E, Thompson R, Sejersen T, McMillan HJ, Kirschner J, Lochm\u00fcller H (2020) Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol 35:643\u2013653","journal-title":"Eur J Epidemiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0888-7543(88)90091-2","article-title":"Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies","volume":"2","author":"Forrest S","year":"1988","unstructured":"Forrest S, Cross G, Flint T, Speer A, Robson K, Davies K (1988) Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics 2:109\u2013114","journal-title":"Genomics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-w","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti JM","year":"1991","unstructured":"Ervasti JM, Campbell KP (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66:1121\u20131131. 10.1016\/0092-8674(91)90035-w","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1083\/jcb.112.1.135","article-title":"Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma","volume":"112","author":"Ohlendieck K","year":"1991","unstructured":"Ohlendieck K, Ervasti JM, Snook JB, Campbell KP (1991) Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112:135\u2013148. 10.1083\/jcb.112.1.135","journal-title":"J Cell Biol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/1097\u20134598","article-title":"Molecular basis of muscular dystrophies","volume":"23","author":"Cohn RD","year":"2000","unstructured":"Cohn RD, Campbell KP (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23:1456\u20131471. 10.1002\/1097\u20134598(200010)23:10\u2009<\u20091456::AID-MUS2\u2009>\u20093.0.CO;2-T [pii]","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.1073\/pnas.0906545106","article-title":"Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan","volume":"106","author":"Han R","year":"2009","unstructured":"Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K et al (2009) Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci USA 106:12573\u201312579. 10.1073\/pnas.0906545106","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07639-3","article-title":"Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle","volume":"9","author":"Olthoff JT","year":"2018","unstructured":"Olthoff JT, Lindsay A, Abo-Zahrah R, Baltgalvis KA, Patrinostro X, Belanto JJ, Yu DY, Perrin BJ, Garry DJ, Rodney GG, Lowe DA, Ervasti JM (2018) Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle. Nat Commun 9. 10.1038\/s41467-018-07639-3","journal-title":"Nat Commun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/01.wco.0000093100.34793.81","article-title":"Cardiomyopathy in muscular dystrophies","volume":"16","author":"Muntoni F","year":"2003","unstructured":"Muntoni F (2003) Cardiomyopathy in muscular dystrophies. Curr Opin Neurol 16:577\u2013583. 10.1097\/01.wco.0000093100.34793.81","journal-title":"Curr Opin Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.22097","article-title":"Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions","volume":"44","author":"Spurney CF","year":"2011","unstructured":"Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8\u201319. 10.1002\/mus.22097","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/d41573-023-00103-y","article-title":"FDA approves first gene therapy for Duchenne muscular dystrophy, despite internal objections","volume":"22","author":"Mullard A","year":"2023","unstructured":"Mullard A (2023) FDA approves first gene therapy for Duchenne muscular dystrophy, despite internal objections. Nat Rev Drug Discov 22:610. 10.1038\/d41573-023-00103-y","journal-title":"Nat Rev Drug Discov"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England SB","year":"1990","unstructured":"England SB, Nicholson LV, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, Harris JB, Davies KE (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343:180\u2013182. 10.1038\/343180a0","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1000958","DOI":"10.1371\/journal.pgen.1000958","article-title":"The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins","volume":"6","author":"Banks GB","year":"2010","unstructured":"Banks GB, Judge LM, Allen JM, Chamberlain JS (2010) The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins. PLoS Genet 6:e1000958. 10.1371\/journal.pgen.1000958","journal-title":"PLoS Genet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic P","year":"2006","unstructured":"Gregorevic P, Allen JM, Minami E, Blankinship MJ, Haraguchi M, Meuse L, Finn E, Adams ME, Froehner SC, Murry CE, Chamberlain JS (2006) rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12:787\u2013789. 10.1038\/nm1439","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of Novel Micro-dystrophins with Enhanced Functionality","volume":"27","author":"Ramos JN","year":"2019","unstructured":"Ramos JN, Hollinger K, Bengtsson NE, Allen JM, Hauschka SD, Chamberlain JS (2019) Development of Novel Micro-dystrophins with Enhanced Functionality. Mol therapy: J Am Soc Gene Therapy 27:623\u2013635. 10.1016\/j.ymthe.2019.01.002","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"eabo1815","DOI":"10.1126\/scitranslmed.abo1815","article-title":"Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy","volume":"15","author":"Birch SM","year":"2023","unstructured":"Birch SM, Lawlor MW, Conlon TJ, Guo LJ, Crudele JM, Hawkins EC, Nghiem PP, Ahn M, Meng H, Beatka MJ, Fickau BA et al (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Sci Transl Med 15:eabo1815. 10.1126\/scitranslmed.abo1815","journal-title":"Sci Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01929-x","author":"Hoy SM","year":"2023","unstructured":"Hoy SM (2023) Delandistrogene Moxeparvovec: First Approval. Drugs 83, 1323\u20131329. 10.1007\/s40265-023-01929-x"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper SQ","year":"2002","unstructured":"Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, Chamberlain JS (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8:253\u2013261. 10.1038\/nm0302-253","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","article-title":"AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >\u200921-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy","volume":"53","author":"Bostick B","year":"2012","unstructured":"Bostick B, Shin JH, Yue Y, Wasala NB, Lai Y, Duan D (2012) AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >\u200921-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J Mol Cell Cardiol 53:217\u2013222. 10.1016\/j.yjmcc.2012.05.002","journal-title":"J Mol Cell Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/hum.2022.180","article-title":"The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"34","author":"Wasala LP","year":"2023","unstructured":"Wasala LP, Watkins TB, Wasala NB, Burke MJ, Yue Y, Lai Y, Yao G, Duan D (2023) The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy. Hum Gene Ther 34:459\u2013470. 10.1089\/hum.2022.180","journal-title":"Hum Gene Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nbt0702-697","article-title":"Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene","volume":"20","author":"Halbert CL","year":"2002","unstructured":"Halbert CL, Allen JM, Miller AD (2002) Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20:697\u2013701. 10.1038\/nbt0702-697","journal-title":"Nat Biotechnol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/mt.2010.205","article-title":"Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6","volume":"19","author":"Odom GL","year":"2011","unstructured":"Odom GL, Gregorevic P, Allen JM, Chamberlain JS (2011) Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Mol therapy: J Am Soc Gene Therapy 19:36\u201345. 10.1038\/mt.2010.205","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/acn3.172","article-title":"AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models","volume":"2","author":"Sondergaard PC","year":"2015","unstructured":"Sondergaard PC, Griffin DA, Pozsgai ER, Johnson RW, Grose WE, Heller KN, Shontz KM, Montgomery CL, Liu J, Clark KR, Sahenk Z et al (2015) AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models. Ann Clin Transl Neurol 2:256\u2013270. 10.1002\/acn3.172","journal-title":"Ann Clin Transl Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.9","author":"Pryadkina M","year":"2015","unstructured":"Pryadkina M, Lostal W, Bourg N, Charton K, Roudaut C, Hirsch ML, Richard I (2015) A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence. Molecular therapy. Methods & clinical development 2, 15009. 10.1038\/mtm.2015.9"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/75080","article-title":"A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation","volume":"6","author":"Duan D","year":"2000","unstructured":"Duan D, Yue Y, Yan Z, Engelhardt JF (2000) A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat Med 6:595\u2013598. 10.1038\/75080","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1073\/pnas.97.12.6716","article-title":"Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy","volume":"97","author":"Yan Z","year":"2000","unstructured":"Yan Z, Zhang Y, Duan D, Engelhardt JF (2000) Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci U S A 97:6716\u20136721. 10.1073\/pnas.97.12.6716","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/sj.mt.6300322","article-title":"A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner","volume":"16","author":"Ghosh A","year":"2008","unstructured":"Ghosh A, Yue Y, Lai Y, Duan D (2008) A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol therapy: J Am Soc Gene Therapy 16:124\u2013130. 10.1038\/sj.mt.6300322","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1089\/hum.2013.164","article-title":"Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice","volume":"25","author":"Koo T","year":"2014","unstructured":"Koo T, Popplewell L, Athanasopoulos T, Dickson G (2014) Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Hum Gene Ther 25:98\u2013108. 10.1089\/hum.2013.164","journal-title":"Hum Gene Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23996-y","article-title":"Efficient precise in vivo base editing in adult dystrophic mice","volume":"12","author":"Xu L","year":"2021","unstructured":"Xu L, Zhang C, Li H, Wang P, Gao Y, Mokadam NA, Ma J, Arnold WD, Han R (2021) Efficient precise in vivo base editing in adult dystrophic mice. Nat Commun 12. 10.1038\/s41467-021-23996-y","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13578-023-01036-0","article-title":"Liver-specific in vivo base editing of Angptl3 via AAV delivery efficiently lowers blood lipid levels in mice","volume":"13","author":"Zuo Y","year":"2023","unstructured":"Zuo Y, Zhang C, Zhou Y, Li H, Xiao W, Herzog RW, Xu J, Zhang J, Chen YE, Han R (2023) Liver-specific in vivo base editing of Angptl3 via AAV delivery efficiently lowers blood lipid levels in mice. Cell Biosci 13:109. 10.1186\/s13578-023-01036-0","journal-title":"Cell Biosci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy JM","year":"2020","unstructured":"Levy JM, Yeh WH, Pendse N, Davis JR, Hennessey E, Butcher R, Koblan LW, Comander J, Liu Q, Liu DR (2020) Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat Biomed Eng 4:97\u2013110. 10.1038\/s41551-019-0501-5","journal-title":"Nat Biomed Eng"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar M","year":"2021","unstructured":"Tabebordbar M, Lagerborg KA, Stanton A, King EM, Ye S, Tellez L, Krunnfusz A, Tavakoli S, Widrick JJ, Messemer KA, Troiano EC et al (2021) Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184:4919\u20134938e4922. 10.1016\/j.cell.2021.08.028","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1021\/jacs.5b13528","article-title":"Design of a Split Intein with Exceptional Protein Splicing Activity","volume":"138","author":"Stevens AJ","year":"2016","unstructured":"Stevens AJ, Brown ZZ, Shah NH, Sekar G, Cowburn D, Muir TW (2016) Design of a Split Intein with Exceptional Protein Splicing Activity. J Am Chem Soc 138:2162\u20132165. 10.1021\/jacs.5b13528","journal-title":"J Am Chem Soc"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"28686","DOI":"10.1074\/jbc.M112.372680","article-title":"Unprecedented rates and efficiencies revealed for new natural split inteins from metagenomic sources","volume":"287","author":"Carvajal-Vallejos P","year":"2012","unstructured":"Carvajal-Vallejos P, Pallisse R, Mootz HD, Schmidt SR (2012) Unprecedented rates and efficiencies revealed for new natural split inteins from metagenomic sources. J Biol Chem 287:28686\u201328696. 10.1074\/jbc.M112.372680","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1128\/MCB.15.8.4086","article-title":"Synthetic signals for ubiquitin-dependent proteolysis","volume":"15","author":"Sadis S","year":"1995","unstructured":"Sadis S, Atienza C Jr., Finley D (1995) Synthetic signals for ubiquitin-dependent proteolysis. Mol Cell Biol 15:4086\u20134094. 10.1128\/MCB.15.8.4086","journal-title":"Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01989-0","article-title":"Control of mammalian gene expression by modulation of polyA signal cleavage at 5' UTR","author":"Luo L","year":"2024","unstructured":"Luo L, Jea JD, Wang Y, Chao PW, Yen L (2024) Control of mammalian gene expression by modulation of polyA signal cleavage at 5' UTR. Nat Biotechnol. 10.1038\/s41587-023-01989-0","journal-title":"Nat Biotechnol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"28792","DOI":"10.1074\/jbc.M115.677237","article-title":"An Unprecedented Combination of Serine and Cysteine Nucleophiles in a Split Intein with an Atypical Split Site","volume":"290","author":"Bachmann AL","year":"2015","unstructured":"Bachmann AL, Mootz HD (2015) An Unprecedented Combination of Serine and Cysteine Nucleophiles in a Split Intein with an Atypical Split Site. J Biol Chem 290:28792\u201328804. 10.1074\/jbc.M115.677237","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/anie.201307969","article-title":"An atypical naturally split intein engineered for highly efficient protein labeling","volume":"53","author":"Thiel IV","year":"2014","unstructured":"Thiel IV, Volkmann G, Pietrokovski S, Mootz HD (2014) An atypical naturally split intein engineered for highly efficient protein labeling. Angew Chem 53:1306\u20131310. 10.1002\/anie.201307969","journal-title":"Angew Chem"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"11791","DOI":"10.1021\/jacs.8b07334","article-title":"An Atypical Mechanism of Split Intein Molecular Recognition and Folding","volume":"140","author":"Stevens AJ","year":"2018","unstructured":"Stevens AJ, Sekar G, Gramespacher JA, Cowburn D, Muir TW (2018) An Atypical Mechanism of Split Intein Molecular Recognition and Folding. J Am Chem Soc 140:11791\u201311799. 10.1021\/jacs.8b07334","journal-title":"J Am Chem Soc"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1073\/pnas.2003613117","article-title":"Live-cell protein engineering with an ultra-short split intein","volume":"117","author":"Burton AJ","year":"2020","unstructured":"Burton AJ, Haugbro M, Parisi E, Muir TW (2020) Live-cell protein engineering with an ultra-short split intein. Proc Natl Acad Sci U S A 117:12041\u201312049. 10.1073\/pnas.2003613117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/6981","article-title":"Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences","volume":"17","author":"Li X","year":"1999","unstructured":"Li X, Eastman EM, Schwartz RJ, Draghia-Akli R (1999) Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat Biotechnol 17:241\u2013245. 10.1038\/6981","journal-title":"Nat Biotechnol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ymthe.2022.11.012","article-title":"Systemic AAV9.BVES delivery ameliorates muscular dystrophy in a mouse model of LGMDR25","volume":"31","author":"Li H","year":"2023","unstructured":"Li H, Wang P, Hsu E, Pinckard KM, Stanford KI, Han R (2023) Systemic AAV9.BVES delivery ameliorates muscular dystrophy in a mouse model of LGMDR25. Mol therapy: J Am Soc Gene Therapy 31:398\u2013408. 10.1016\/j.ymthe.2022.11.012","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41467-023-37496-8","article-title":"Defective BVES-mediated feedback control of cAMP in muscular dystrophy","volume":"14","author":"Li H","year":"2023","unstructured":"Li H, Wang P, Zhang C, Zuo Y, Zhou Y, Han R (2023) Defective BVES-mediated feedback control of cAMP in muscular dystrophy. Nat Commun 14:1785. 10.1038\/s41467-023-37496-8","journal-title":"Nat Commun"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/hmg\/ddab133","article-title":"Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin","volume":"30","author":"Wang H","year":"2021","unstructured":"Wang H, Marrosu E, Brayson D, Wasala NB, Johnson EK, Scott CS, Yue Y, Hau KL, Trask AJ, Froehner SC, Adams ME et al (2021) Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin. Hum Mol Genet 30:1321\u20131336. 10.1093\/hmg\/ddab133","journal-title":"Hum Mol Genet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1089\/hum.2008.009","article-title":"Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy","volume":"19","author":"Li J","year":"2008","unstructured":"Li J, Sun W, Wang B, Xiao X, Liu XQ (2008) Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. Hum Gene Ther 19:958\u2013964. 10.1089\/hum.2008.009","journal-title":"Hum Gene Ther"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/sj.mt.6300268","article-title":"The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene","volume":"15","author":"Chen L","year":"2007","unstructured":"Chen L, Zhu F, Li J, Lu H, Jiang H, Sarkar R, Arruda VR, Wang J, Zhao J, Pierce GF, Ding Q et al (2007) The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther 15:1856\u20131862. 10.1038\/sj.mt.6300268","journal-title":"Mol Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/hmg\/11.9.1095","article-title":"Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy","volume":"11","author":"Warner LE","year":"2002","unstructured":"Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, Ervasti JM, Chamberlain JS (2002) Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet 11:1095\u20131105. 10.1093\/hmg\/11.9.1095","journal-title":"Hum Mol Genet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"294ra106","DOI":"10.1126\/scitranslmed.aaa4804","article-title":"Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment","volume":"7","author":"Barnabei MS","year":"2015","unstructured":"Barnabei MS, Sjaastad FV, Townsend D, Bedada FB, Metzger JM (2015) Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment. Sci Transl Med 7:294ra106. 10.1126\/scitranslmed.aaa4804","journal-title":"Sci Transl Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pro.3357","article-title":"Improved protein splicing using embedded split inteins","volume":"27","author":"Gramespacher JA","year":"2018","unstructured":"Gramespacher JA, Stevens AJ, Thompson RE, Muir TW (2018) Improved protein splicing using embedded split inteins. Protein Sci 27:614\u2013619. 10.1002\/pro.3357","journal-title":"Protein Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19230-w","author":"Weinmann J","year":"2020","unstructured":"Weinmann J, Weis S, Sippel J, Tulalamba W, Remes A, El Andari J, Herrmann AK, Pham QH, Borowski C, Hille S, Schonberger T et al (2020) Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nature communications 11, 5432. 10.1038\/s41467-020-19230-w"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn4704","author":"Andari J","year":"2022","unstructured":"El Andari J, Renaud-Gabardos E, Tulalamba W, Weinmann J, Mangin L, Pham QH, Hille S, Bennett A, Attebi E, Bourges E, Leborgne C et al (2022) Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders. Science advances 8, eabn4704. 10.1126\/sciadv.abn4704"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","article-title":"RGD and other recognition sequences for integrins","volume":"12","author":"Ruoslahti E","year":"1996","unstructured":"Ruoslahti E (1996) RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12:697\u2013715. 10.1146\/annurev.cellbio.12.1.697","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy","volume":"388","author":"Bonnemann CG","year":"2023","unstructured":"Bonnemann CG, Belluscio BA, Braun S, Morris C, Singh T, Muntoni F (2023) Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy. N Engl J Med 388:2294\u20132296. 10.1056\/NEJMc2212912","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria SM","year":"2024","unstructured":"Salabarria SM, Corti M, Coleman KE, Wichman MB, Berthy JA, D'Souza P, Tifft CJ, Herzog RW, Elder ME, Shoemaker LR, Leon-Astudillo C et al (2024) Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies. J Clin Invest 134. 10.1172\/JCI173510","journal-title":"J Clin Invest"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ymthe.2024.03.016","article-title":"Immune tolerance induction by hepatic gene transfer: First-in-human evidence","volume":"32","author":"Kaczmarek R","year":"2024","unstructured":"Kaczmarek R, Samelson-Jones BJ, Herzog RW (2024) Immune tolerance induction by hepatic gene transfer: First-in-human evidence. Mol therapy: J Am Soc Gene Therapy 32:863\u2013864. 10.1016\/j.ymthe.2024.03.016","journal-title":"Mol therapy: J Am Soc Gene Therapy"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3867299\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3867299\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T07:52:14Z","timestamp":1721548334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3867299\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":54,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3867299\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-024-50569-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,5,3]]},"subtype":"preprint"}}